Detalhe da pesquisa
1.
Hypopituitarism.
Lancet
; 403(10444): 2632-2648, 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735295
2.
Cushing's syndrome.
Lancet
; 402(10418): 2237-2252, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37984386
3.
Medical treatment of functional pituitary adenomas, trials and tribulations.
J Neurooncol
; 168(2): 197-213, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760632
4.
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes.
Pituitary
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709467
5.
Acromegaly and COVID-19, lessons, and new opportunities.
Pituitary
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819618
6.
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing's syndrome: a large population database study.
Pituitary
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769229
7.
Consensus on criteria for acromegaly diagnosis and remission.
Pituitary
; 27(1): 7-22, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37923946
8.
Cushing's syndrome in women: age-related differences in etiology and clinical picture.
Pituitary
; 26(1): 144-151, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515786
9.
Cushing Syndrome: A Review.
JAMA
; 330(2): 170-181, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432427
10.
COVID-19 and hypopituitarism.
Rev Endocr Metab Disord
; 23(2): 215-231, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387832
11.
Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples.
Pituitary
; 25(6): 795-809, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002784
12.
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience.
Pituitary
; 25(3): 420-432, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022929
13.
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States.
Pituitary
; 25(2): 296-307, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973139
14.
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2).
Pituitary
; 25(6): 959-970, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219274
15.
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.
Pituitary
; 25(1): 64-73, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283370
16.
Levoketoconazole in the treatment of patients with endogenous Cushing's syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS).
Pituitary
; 25(6): 911-926, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36085339
17.
Personalized Medical Treatment of Patients With Acromegaly: A Review.
Endocr Pract
; 28(3): 321-332, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35032649
18.
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.
Pituitary
; 24(1): 104-115, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216275
19.
A Pituitary Society update to acromegaly management guidelines.
Pituitary
; 24(1): 1-13, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079318
20.
Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection.
Pituitary
; 24(6): 839-853, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34231079